Loss of CAV1 in tumor stroma confers poor outcomes in prostate, breast, ovarian, esophageal, gastric, liver, and pancreatic cancers and melanoma [26,35,91,102]. This evidence concerns the gene CAV1 and pancreatic neoplasm.